Is BioMarin Stock Oversold At $77?
- Friday, September 4, 2020, 7:12
- Market
- Add a comment
After a 30% drop in August this year, at the current price of around $77 per share we believe BioMarin’s stock, a relatively small pharmaceutical company, looks oversold and it can offer significant upside. BMRN stock has moved from $120 to $78 in the month of August compared to the S&P which…
About the Author
admin123 has written 23527 stories on this site.
